Closing Proceeds. The Company shall have raised at least $40,000,000 from the Investors pursuant to this Agreement; provided, however, that, notwithstanding Section 10.2, this condition may be waived solely by MPM Capital.
Appears in 4 contracts
Sources: Common Stock and Warrant Purchase Agreement (Rigel Pharmaceuticals Inc), Common Stock and Warrant Purchase Agreement (MPM Bio Ventures Iii Lp), Common Stock and Warrant Purchase Agreement (Frazier Healthcare Ii Lp)